Contribute Try STAT+ Today

In a move that has concerned the pharmaceutical industry, the El Salvadoran health and economy ministers reportedly want to change existing law to allow the government to issue compulsory licenses for medicines used to combat non-communicable diseases, such as diabetes and cancer.

By doing so, the government would be able to “react to cases of epidemics, prevalent diseases, and public health crises in a timely manner,” Giovannia Guevara, director of health technologies in the Health Ministry, told El Mundo. The reform “will give us additional tools to those we already have to defend the population’s right to health.” Guevara did not respond to a request for comment.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.